| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 0.0007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0009 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |